2025-06-02-Jefferies-SaaS服务经济周报_XPOF分析师日把握正确重点_12页_265kb

报告摘要

Equity Research Summary: EWCZ

Company Overview: European Wax Center (EWCZ) is a leading franchisor and operator of out-of-home waxing services in the US. It is the largest and fastest-growing system by number of centers (over 1000 locations across 40+ states) and systemwide sales (~$900M in 2022), specializing in hair removal franchises.
Financial Highlights:
- Rating and Price Target: BUY, $15 target (reflecting ~15x EV/EBITDA based on 2026E EBITDA of ~$75M).
- Revenue and EBITDA: 2023 revenue reached $221M, with EBITDA of $76M. Projected to grow modestly, with EBITDA around $70M in 2025 and $75-87M in 2026. Valuation metrics show EV/EBITDA of 8x and P/Rev of 1.3-1.4x.
- Key Metrics: Strong gross margins (71.7%-74.2%), recurring revenue from Wax Pass sales driving predictable growth.
Investment Thesis:
- Positives: Robust brand recognition, recurring revenue model via Wax Pass (upside from consumer adoption), and significant unit development opportunities in a fragmented industry.
- Upside Scenario: Wax Pass program adoption accelerates, increasing revenue and EBITDA beyond base case (e.g., $24 PT scenario if EBITDA reaches $87M by 2026).
- Downside Risks: Macroeconomic headwinds (e.g., reduced consumer spending), increased competition, and consumer churn could depress sales by up to -42% (as in the $3 downside PT).
Catalysts and Risks:
- Catalysts: Unit expansion, marketing enhancements for Wax Pass, and potential new services like laser hair removal.
- Risks: Slowing economy, competition, and supply chain issues could hamper growth. Historical price targets show volatility in the SaaS sector, with previous targets ranging from $23 to $9 ratings changes.
ESG and Sustainability: Focus on environmental practices (e.g., sustainable wax sourcing), diversity (females >60% of leadership), and employee development programs.
Analyst Outlook: Jefferies analysts certify the views are based on extensive data and projections, emphasizing recurring revenue potential but cautioning on macro sensitivity.